Latest drug resistance News

New antibody-like molecule which could be used in therapy to prevent infection from multiple forms of malaria
The cause of the genome’s commonest mutation has been reassigned
Antiviral-resistant SARS-CoV-2 variants can emerge in immunocompromised people
Ignore antifungal resistance in fungal disease at your peril, warn top scientists
Study proves transfer of feline coronavirus between domestic and wild cats
Breakthrough in the hunt for broad-spectrum malaria therapy
Noxopharm reports results from Chroma platform drug development program
Scientists discover superbug’s rapid path to antibiotic resistance
University of Manchester scientists joins three networks to tackle antimicrobial resistance
Long-acting injectable lenacapavir proves effective in HIV prevention for women
The final stretch to reaching 95-95-95 targets: supporting re-engagement in HIV treatment
New Discoveries Reveal That TRP14 (TXNDC17) Is A Crucial Enzyme for Cysteine Metabolism and Disease Resistance
Funding boost for Curtin tool to predict chemo effectiveness
WHO releases report on state of development of antibacterials
Ludwig Cancer Research Scientists to Present at AACR Annual Meeting
Strengthening surveillance and response for vector-borne diseases
Gut microbiome: meet Klebsiella pneumoniae – an opportunistic pathogen that is harmless to some, but causes severe disease in others
Liquid crystal nanoparticles supercharge antibiotics for cystic fibrosis
WHO World TB Day Message
WHO launches new guidance on the use of targeted next-generation sequencing tests for the diagnosis of drug-resistant TB and a new sequencing portal
AI can help predict whether a patient will respond to specific tuberculosis treatments, paving way for personalized care
Eliminating Malaria Requires New Solutions
New report documents increase in HIV drug resistance to dolutegravir
Studying Metastases And Drug Resistance In Lung Cancer
Synthetic polymers provide hope in the fight against invasive fungal infections
Drug-resistant TB responds rapidly to bedaquiline-based therapy
Parasite insights: the award-winning scientist teaching the world about deadly diseases
Bacteria can develop resistance to drugs they haven’t encountered before − scientists figured this out decades ago in a classic experiment
Prostate cancer treatment given new hope with MRFF win
Innovative modelling may help breast cancer patients who don’t respond to treatment
How a timekeeping gene affects tumor growth depends entirely on context
Structural study points way to better malaria drugs
Five Ludwig Cancer Research scientists named Fellows of the American Association for Cancer Research
Crop spray could lead to mass resistance in new-generation antifungal treatments
Grants will fund tuberculosis drug development
EnGeneIC’s breakthrough Armed Nanocell Drug Conjugate (ANDC) treatment shows promising results in Pancreatic cancer patients who have run out of treatment options
Drug resistance may make common infections like thrush untreatable
Preserving antimicrobials for the well-being of humans, animals, plants and ecosystems
November is Pancreatic Cancer Awareness Month
Leukaemia Foundation and HSANZ funding next generation of clinicians and researchers to save more Australian lives
WHO announces the members of the first Taskforce of AMR Survivors
HKUST-led Research Unveils Early Predictors of Glioma Evolution by CELLO2
Residue from household disinfectants may be leading to drug resistance in deadly bacteria
New target to beat cancer drug resistance
Ultrathin nanotech promises to help tackle antibiotic resistance
Botswana National HIV Reference Laboratory designated WHO Collaborating Centre of Excellence
WHO issues rapid communication on use of targeted next-generation sequencing for diagnosis of drug-resistant tuberculosis
Tumor metabolism atlas can help discover cancer mechanisms